LAGOS, NIGERIA — The National Agency for Food and Drug Administration and Control (NAFDAC) has deployed 600 qualified pharmacists across Nigeria’s 36 states and the Federal Capital Territory. This coordinated regulatory program addresses the escalating nafdac counterfeit medicine epidemic, which continues to infiltrate community drug markets and endanger patient safety. NAFDAC Director-General Prof. Mojisola Adeyeye emphasized that centralized oversight from the capital cannot effectively protect over 200 million people without localized enforcement presence.
The volunteer pharmacists undergo rigorous training in pharmacovigilance, compliance monitoring, antimicrobial resistance prevention, and drug enforcement protocols. Deployment prioritizes high-risk environments, including informal community pharmacies, open-air drug markets, and primary healthcare centers where vulnerable populations face the highest exposure to substandard products.
Key Volunteer Program Benchmarks & Operational Pillars
The national regulatory initiative combines professional incentives with expanded market surveillance:
Regulatory Pillar
Target Deliverables & Operational Metrics
Field Focus
Workforce Deployment
600 pharmacist volunteers across 36 states & FCT
Local market & community surveillance
Priority Targeted Outlets
Informal pharmacies, open markets, primary health centers
High-vulnerability drug distribution points
Volunteer Support Package
Professional allowances, CE credits & liability coverage
Professionalization of volunteer inspectors
Enforcement Integration
Mobile reporting apps, sample collection & lab testing
Rapid supply chain tracking & product seizures
Combating the Nafdac Counterfeit Medicine Epidemic Through Local Action
Neutralizing the nafdac counterfeit medicine epidemic requires multi-tiered regulatory and technological integration. Volunteer pharmacists receive official certification enabling them to execute facility inspections, collect product samples, and log compliance violations directly to NAFDAC headquarters using rapid digital reporting tools. International partnerships complement these field efforts by tracking cross-border trade routes and identifying counterfeit manufacturing origins.
Simultaneously, public education campaigns inform vendors and consumers on how to identify packaging red flags and report suspicious pharmaceuticals. By combining community-level inspections with enhanced laboratory testing capacity and supply chain verification, NAFDAC’s volunteer model establishes a scalable framework for drug quality enforcement across Africa.
Why It Matters: NAFDAC’s pharmacist volunteer deployment extends regulatory presence throughout Nigeria, addressing counterfeit medicines at the community level where patient exposure is greatest.
Drug Safety in Africa: The Power of Pharmacovigilance Access to medicines is vital for saving lives, but ensuring that those medicines are safe, effective, and of high quality is equally important. Across Africa, drug safety remains a major concern, with counterfeit, substandard, and…
How Misuse of Antibiotics Fuels Superbugs in Africa Antimicrobial resistance (AMR) is one of the biggest public health threats of the 21st century. Across the globe, the misuse and overuse of antibiotics have led to the rise of “superbugs” – bacteria, viruses, fungi,…
NAFDAC Trains Pharmacists Reserve For National… LAGOS, NIGERIA — Nigeria's National Agency for Food and Drug Administration and Control (NAFDAC) enrolled 600 pharmacists in its Pharmacists Reserve Volunteer Program on 14 September 2026. Deploying a NAFDAC trains pharmacists reserve force represents…
Counterfeit Medicine Crisis Rooted in Regulatory Gaps LAGOS, NIGERIA — Professor Mojisola Adeyeye, Director-General of NAFDAC, has linked the counterfeit medicine crisis in Nigeria to three decades of institutional regulatory gaps. Speaking on September 9, 2026, Adeyeye outlined how historical oversights in…
